SPECTRAL MEDICAL INC (EDT.CA) Stock Price, Forecast & Analysis
Canada - Toronto Stock Exchange - TSX:EDT - CA8475771033 - Common Stock
EDT.CA Key Statistics, Chart & Performance
The current stock price of EDT.CA is 1.44 CAD. In the past month the price increased by 15.2%. In the past year, price increased by 161.82%.
EDT.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| EPRX.CA | EUPRAXIA PHARMACEUTICALS INC | N/A | 522.71M | ||
| HBP.CA | HELIX BIOPHARMA CORP | N/A | 181.02M | ||
| MDNA.CA | MEDICENNA THERAPEUTICS CORP | N/A | 76.74M | ||
| COV.CA | COVALON TECHNOLOGIES LTD | 24.86 | 48.06M | ||
| MBX.CA | MICROBIX BIOSYSTEMS INC | N/A | 31.97M | ||
| RVX.CA | RESVERLOGIX CORP | N/A | 28.73M | ||
| BCT.CA | BRIACELL THERAPEUTICS CORP | N/A | 18.42M | ||
| HEM.CA | HEMOSTEMIX INC | N/A | 16.96M | ||
| MPH.CA | MEDICURE INC | N/A | 11.90M | ||
| CSCI.CA | COSCIENS BIOPHARMA INC | N/A | 9.03M | ||
| KNE.CA | KANE BIOTECH INC | N/A | 6.69M | ||
| QPT.CA | QUEST PHARMATECH INC | N/A | 5.92M |
Related stock screener links
About EDT.CA
Company Profile
Spectral Medical, Inc. engages in the development and commercialization of therapeutic treatment for septic shock. The company is headquartered in Toronto, Ontario and currently employs 29 full-time employees. The firm develops and commercializes Toraymyxin (PMX), a therapeutic hemoperfusion device designed to remove endotoxins from the bloodstream, which are a major cause of sepsis. The firm also offers the Endotoxin Activity Assay (EAA), the diagnostic test for detecting endotoxin levels in blood, and it provides an endotoxin activity result normally between 0.0 and 1.0. The company provides reagents for both research and commercial applications. Their product line includes monoclonal antibodies and recombinant proteins, which are essential for developing advanced diagnostic tools. Additionally, the Company is conducting the Tigris Clinical Trial, a confirmatory study evaluating PMX in combination with standard care versus standard care alone, using Bayesian statistical analysis.
Company Info
SPECTRAL MEDICAL INC
135 The West Mall, Unit 2
TORONTO ONTARIO M9C 1C2 CA
CEO: Chris Seto
Employees: 29
Phone: 14166263233
SPECTRAL MEDICAL INC / EDT.CA FAQ
What does SPECTRAL MEDICAL INC do?
Spectral Medical, Inc. engages in the development and commercialization of therapeutic treatment for septic shock. The company is headquartered in Toronto, Ontario and currently employs 29 full-time employees. The firm develops and commercializes Toraymyxin (PMX), a therapeutic hemoperfusion device designed to remove endotoxins from the bloodstream, which are a major cause of sepsis. The firm also offers the Endotoxin Activity Assay (EAA), the diagnostic test for detecting endotoxin levels in blood, and it provides an endotoxin activity result normally between 0.0 and 1.0. The company provides reagents for both research and commercial applications. Their product line includes monoclonal antibodies and recombinant proteins, which are essential for developing advanced diagnostic tools. Additionally, the Company is conducting the Tigris Clinical Trial, a confirmatory study evaluating PMX in combination with standard care versus standard care alone, using Bayesian statistical analysis.
What is the current price of EDT stock?
The current stock price of EDT.CA is 1.44 CAD. The price increased by 9.92% in the last trading session.
Does EDT stock pay dividends?
EDT.CA does not pay a dividend.
How is the ChartMill rating for SPECTRAL MEDICAL INC?
EDT.CA has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
How is the market expecting EDT stock to perform?
6 analysts have analysed EDT.CA and the average price target is 3.16 CAD. This implies a price increase of 119.58% is expected in the next year compared to the current price of 1.44.
How many employees does SPECTRAL MEDICAL INC have?
SPECTRAL MEDICAL INC (EDT.CA) currently has 29 employees.
Can you provide the market cap for SPECTRAL MEDICAL INC?
SPECTRAL MEDICAL INC (EDT.CA) has a market capitalization of 416.39M CAD. This makes EDT.CA a Small Cap stock.
EDT.CA Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to EDT.CA. When comparing the yearly performance of all stocks, EDT.CA is one of the better performing stocks in the market, outperforming 87.59% of all stocks.
EDT.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to EDT.CA. Both the profitability and financial health of EDT.CA have multiple concerns.
EDT.CA Financial Highlights
Over the last trailing twelve months EDT.CA reported a non-GAAP Earnings per Share(EPS) of -0.15. The EPS decreased by -62.68% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -513.23% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
EDT.CA Forecast & Estimates
6 analysts have analysed EDT.CA and the average price target is 3.16 CAD. This implies a price increase of 119.58% is expected in the next year compared to the current price of 1.44.
For the next year, analysts expect an EPS growth of 14.29% and a revenue growth -14.99% for EDT.CA